General Information
Mycophenolate Mofetil API in finished dosage forms is an antimetabolite immunosuppressant used in combination with other immunosuppressants, and is indicated for the prophylaxis of organ rejection in those who have received kidney, heart or liver transplants.
About the API
Technology
Fermentation
Therapeutic category
Immunology
Available formulations
Oral Liquid
Oral Solid
Regulations
Canada DMF
CEP
EU DMF
Japan DMF
Other
US DMF
Canada DMF
CEP
EU DMF
Japan DMF
Other
US DMF